Literature DB >> 9590143

Factors affecting the rate of iron mobilization during venesection therapy for genetic hemochromatosis.

P C Adams1.   

Abstract

Although progressive iron accumulation is a characteristic feature of genetic hemochromatosis, the factors affecting the rate of iron mobilization by venesection have not been established. Venesection records were analyzed in 77 hemochromatosis homozygotes to study the factors affecting the rate of iron mobilization by venesection. The rate of iron mobilization was the iron removed divided by the time required to deplete iron stores (serum ferritin < 50 microg/L). Mean duration of venesection therapy was 1.4 years (range 0.44-3.6 years). All patients completed the therapy and there were no significant adverse effects. Rate of iron mobilization was higher in cirrhotics compared to non-cirrhotic patients (P = 0.04). Iron mobilization was inversely related to intestinal radioiron absorption (r = -0.45, P = .01). There was no significant relationship between iron mobilization and patient age, gender, serum ferritin, and hepatic iron concentration. Iron mobilization is increased in cirrhotics and patients with lower intestinal iron absorption. Venesection therapy is safe and well tolerated in all age groups.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9590143     DOI: 10.1002/(sici)1096-8652(199805)58:1<16::aid-ajh3>3.0.co;2-3

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  4 in total

Review 1.  Hemochromatosis. Common genes, uncommon illness?

Authors:  Helen Harrison; Paul C Adams
Journal:  Can Fam Physician       Date:  2002-08       Impact factor: 3.275

2.  Serum ferritin concentrations and body iron stores in a multicenter, multiethnic primary-care population.

Authors:  Victor R Gordeuk; David M Reboussin; Christine E McLaren; James C Barton; Ronald T Acton; Gordon D McLaren; Emily L Harris; Jacob A Reiss; Paul C Adams; Mark Speechley; Pradyumna D Phatak; Phyliss Sholinsky; John H Eckfeldt; Wen-Pin Chen; Leah Passmore; Fitzroy W Dawkins
Journal:  Am J Hematol       Date:  2008-08       Impact factor: 10.047

3.  Initial serum ferritin predicts number of therapeutic phlebotomies to iron depletion in secondary iron overload.

Authors:  Sandhya R Panch; Yu Ying Yau; Kamille West; Karen Diggs; Tamsen Sweigart; Susan F Leitman
Journal:  Transfusion       Date:  2014-09-11       Impact factor: 3.157

4.  A predictive model for estimating the number of erythrocytapheresis or phlebotomy treatments for patients with naïve hereditary hemochromatosis.

Authors:  Eva Rombout-Sestrienkova; Bjorn Winkens; Marian van Kraaij; Cees Th B M van Deursen; Mirian C H Janssen; Alexander M J Rennings; Dorothea Evers; Jean-Louis Kerkhoffs; Ad Masclee; Ger H Koek
Journal:  J Clin Apher       Date:  2020-12-24       Impact factor: 2.821

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.